MétaCan
Menu
Back to cohort
Record W4381893710 · doi:10.1016/j.jhep.2023.06.003

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

2023· review· en· W4381893710 on OpenAlexafffund
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome

Bibliographic record

VenueJournal of Hepatology · 2023
Typereview
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsLondon Health Sciences CentreWestern University
FundersFaculty of Medicine and Health, University of SydneyYonsei University College of MedicineLeibniz-GemeinschaftSchool of Medicine, Indiana UniversityUniversity of California, IrvineSun PharmaUniversidad Abierta InteramericanaFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoPritzker School of MedicineSorbonne UniversitéUniversiteit AntwerpenUniversidade de LisboaNational and Kapodistrian University of AthensHeinrich-Heine-Universität DüsseldorfNovo NordiskCity University of New YorkHelwan UniversityNewcastle upon Tyne Hospitals NHS Foundation TrustGilead SciencesUniversity of BirminghamUniversiteit van AmsterdamCenter for Innovations in Quality, Effectiveness and SafetyEuropean Association for the Study of the LiverNewcastle UniversityUniversity of OxfordUniversity of SouthamptonNational Institute for Health and Care ResearchUniversity of CincinnatiQIMR Berghofer Medical Research InstituteAmsterdam University Medical CentersNGM BiopharmaceuticalsChildren's Healthcare of AtlantaVerily Life SciencesNovavaxUniversity of FloridaInova Health SystemPfizerUniversità degli Studi di MilanoLondon Health Sciences CentreUniversity Hospital Southampton NHS Foundation TrustUniversity Hospitals Birmingham NHS Foundation TrustRegeneron PharmaceuticalsGenentechAlnylam PharmaceuticalsAstraZenecaCollege of Medicine, University of CincinnatiWashington State UniversityVirginia Commonwealth UniversityCincinnati Children's Hospital Medical CenterConsejo Nacional de Investigaciones Científicas y TécnicasU.S. Department of Veterans AffairsInstitut de Cardiométabolisme et NutritionYonsei UniversityBoston PharmaceuticalsUniversidad de SevillaAmerican Association for the Study of Liver DiseasesBristol-Myers SquibbUniversity of Cape TownChinese University of Hong KongEli Lilly and CompanyUniversitat de BarcelonaAmgenUniversity of QueenslandEmory University
KeywordsNomenclatureStatement (logic)Fatty liverDelphiConsensus conferenceMedicineDiseaseInternal medicineBiologyComputer scienceZoologyPolitical scienceLawTaxonomy (biology)Programming language

Abstract

fetched live from OpenAlex

The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient advocates were in favour of a change in nomenclature and/or definition. A modified Delphi process was led by three large pan-national liver associations. The consensus was defined a priori as a supermajority (67%) vote. An independent committee of experts external to the nomenclature process made the final recommendation on the acronym and its diagnostic criteria. A total of 236 panellists from 56 countries participated in 4 online surveys and 2 hybrid meetings. Response rates across the 4 survey rounds were 87%, 83%, 83%, and 78%, respectively. Seventy-four percent of respondents felt that the current nomenclature was sufficiently flawed to consider a name change. The terms "nonalcoholic" and "fatty" were felt to be stigmatising by 61% and 66% of respondents, respectively. Steatotic liver disease was chosen as an overarching term to encompass the various aetiologies of steatosis. The term steatohepatitis was felt to be an important pathophysiological concept that should be retained. The name chosen to replace NAFLD was metabolic dysfunction-associated steatotic liver disease (MASLD). There was consensus to change the definition to include the presence of at least 1 of 5 cardiometabolic risk factors. Those with no metabolic parameters and no known cause were deemed to have cryptogenic steatotic liver disease. A new category, outside pure metabolic dysfunction-associated steatotic liver disease, termed metabolic and alcohol related/associated liver disease (MetALD), was selected to describe those with metabolic dysfunction-associated steatotic liver disease, who consume greater amounts of alcohol per week (140-350 g/wk and 210-420 g/wk for females and males, respectively). The new nomenclature and diagnostic criteria are widely supported and non-stigmatising, and can improve awareness and patient identification.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.318
metaresearch head score (Gemma)0.162
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Reporting · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: Qualitative
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.682
Threshold uncertainty score0.841

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.3180.162
Meta-epidemiology (narrow)0.0010.002
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0060.003
Science and technology studies0.0060.006
Scholarly communication0.0060.007
Open science0.0040.019
Research integrity0.0040.006
Insufficient payload (model declined to judge)0.0060.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.146
GPT teacher head0.406
Teacher spread0.260 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designQualitative
DomainReporting
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2,698
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueJournal of HepatologySame topicLiver Disease Diagnosis and TreatmentFrench-language works237,207